Recent Publications
- Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century
- Erratum: Beyond the definitions of the phenotypic complications of sickle cell disease: An update on management (The Scientific World Journal)
- Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo
- Platelet ITAM signaling is critical for vascular integrity in infammation
- Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation
- Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
- Recent trends in survival of adult patients with acute leukemia: Overall improvements, but persistent and partly increasing disparity in survival of patients from minority groups
- Transfusion medicine illustrated. The first Cardeza donor center: attracting donors who do not wsh to see blood.
- Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs
- Investigations of human platelet-type 12-lipoxygenase: Role of lipoxygenase products in platelet activation
- Sickle cell pain: A critical reappraisal
- Immunoglobulin therapy and thrombosis: Coincidence or causation?
- Drugs for preventing red blood cell dehydration in people with sickle cell disease.
- Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: Is the discrepancy decreasing?
- Beyond the definitions of the phenotypic complications of sickle cell disease: An update on management
- Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1
- Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation
- Subsite-specific colorectal cancer risk in the colorectal endoscopy era
- Rap1-Rac1 circuits potentiate platelet activation
- We can do it together: PAR1/PAR2 heterodimer signaling in VSMCs